2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
Standard
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. / de Thurah, Annette; Bosch, Philipp; Marques, Andrea; Meissner, Yvette; Mukhtyar, Chetan B; Knitza, Johannes; Najm, Aurélie; Østerås, Nina; Pelle, Tim; Knudsen, Line Raunsbæk; Šmucrová, Hana; Berenbaum, Francis; Jani, Meghna; Geenen, Rinie; Krusche, Martin; Pchelnikova, Polina; de Souza, Savia; Badreh, Sara; Wiek, Dieter; Piantoni, Silvia; Gwinnutt, James M; Duftner, Christina; Canhão, Helena M; Quartuccio, Luca; Stoilov, Nikolay; Prior, Yeliz; Bijlsma, Johannes Wj; Zabotti, Alen; Stamm, Tanja A; Dejaco, Christian.
in: ANN RHEUM DIS, Jahrgang 81, Nr. 8, 08.2022, S. 1065-1071.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
AU - de Thurah, Annette
AU - Bosch, Philipp
AU - Marques, Andrea
AU - Meissner, Yvette
AU - Mukhtyar, Chetan B
AU - Knitza, Johannes
AU - Najm, Aurélie
AU - Østerås, Nina
AU - Pelle, Tim
AU - Knudsen, Line Raunsbæk
AU - Šmucrová, Hana
AU - Berenbaum, Francis
AU - Jani, Meghna
AU - Geenen, Rinie
AU - Krusche, Martin
AU - Pchelnikova, Polina
AU - de Souza, Savia
AU - Badreh, Sara
AU - Wiek, Dieter
AU - Piantoni, Silvia
AU - Gwinnutt, James M
AU - Duftner, Christina
AU - Canhão, Helena M
AU - Quartuccio, Luca
AU - Stoilov, Nikolay
AU - Prior, Yeliz
AU - Bijlsma, Johannes Wj
AU - Zabotti, Alen
AU - Stamm, Tanja A
AU - Dejaco, Christian
N1 - © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/8
Y1 - 2022/8
N2 - BACKGROUND: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).OBJECTIVE: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.METHODS: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.RESULTS: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible.The level of agreement to each statement ranged from 8.5 to 9.8/10.CONCLUSION: The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.
AB - BACKGROUND: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).OBJECTIVE: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.METHODS: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.RESULTS: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible.The level of agreement to each statement ranged from 8.5 to 9.8/10.CONCLUSION: The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.
KW - COVID-19
KW - Health Services Accessibility
KW - Humans
KW - Musculoskeletal Diseases/therapy
KW - Pandemics
KW - Telemedicine
U2 - 10.1136/annrheumdis-2022-222341
DO - 10.1136/annrheumdis-2022-222341
M3 - SCORING: Journal article
C2 - 35470160
VL - 81
SP - 1065
EP - 1071
JO - ANN RHEUM DIS
JF - ANN RHEUM DIS
SN - 0003-4967
IS - 8
ER -